Amalgamated Bank’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-879
| Closed | -$1K | – | 3068 |
|
|
2025
Q1 | $1K | Hold |
879
| – | – | ﹤0.01% | 2914 |
|
|
2024
Q4 | $2K | Hold |
879
| – | – | ﹤0.01% | 2907 |
|
|
2024
Q3 | $5K | Hold |
879
| – | – | ﹤0.01% | 2755 |
|
|
2024
Q2 | $7K | Buy |
+879
| New | +$7K | ﹤0.01% | 2612 |
|
|
2023
Q2 | – | Sell |
-2,158
| Closed | -$21K | – | 3074 |
|
|
2023
Q1 | $21K | Sell |
2,158
-503
| -19% | -$4.9K | ﹤0.01% | 2625 |
|
|
2022
Q4 | $50K | Hold |
2,661
| – | – | ﹤0.01% | 2416 |
|
|
2022
Q3 | $55K | Buy |
2,661
+397
| +18% | +$8.21K | ﹤0.01% | 2414 |
|
|
2022
Q2 | $47K | Buy |
2,264
+190
| +9% | +$3.94K | ﹤0.01% | 2517 |
|
|
2022
Q1 | $89K | Sell |
2,074
-160
| -7% | -$6.87K | ﹤0.01% | 2238 |
|
|
2021
Q4 | $134K | Sell |
2,234
-20
| -0.9% | -$1.2K | ﹤0.01% | 2029 |
|
|
2021
Q3 | $194K | Sell |
2,254
-166
| -7% | -$14.3K | ﹤0.01% | 1996 |
|
|
2021
Q2 | $269K | Buy |
2,420
+243
| +11% | +$27K | ﹤0.01% | 1931 |
|
|
2021
Q1 | $242K | Buy |
2,177
+113
| +5% | +$12.6K | 0.01% | 1377 |
|
|
2020
Q4 | $219K | Buy |
2,064
+33
| +2% | +$3.5K | 0.01% | 1401 |
|
|
2020
Q3 | $283K | Buy |
2,031
+113
| +6% | +$15.7K | 0.01% | 1137 |
|
|
2020
Q2 | $620K | Buy |
1,918
+539
| +39% | +$174K | 0.03% | 698 |
|
|
2020
Q1 | $123K | Buy |
1,379
+29
| +2% | +$2.59K | ﹤0.01% | 1463 |
|
|
2019
Q4 | $53K | Hold |
1,350
| – | – | ﹤0.01% | 1787 |
|
|
2019
Q3 | $33K | Sell |
1,350
-12
| -0.9% | -$293 | ﹤0.01% | 1743 |
|
|
2019
Q2 | $48K | Buy |
1,362
+293
| +27% | +$10.3K | ﹤0.01% | 1751 |
|
|
2019
Q1 | $48K | Buy |
1,069
+37
| +4% | +$1.66K | ﹤0.01% | 1650 |
|
|
2018
Q4 | $50K | Buy |
+1,032
| New | +$50K | ﹤0.01% | 1566 |
|
|
2018
Q3 | – | Sell |
-1,051
| Closed | -$49K | – | 1529 |
|
|
2018
Q2 | $49K | Buy |
1,051
+139
| +15% | +$6.48K | ﹤0.01% | 1703 |
|
|
2018
Q1 | $52K | Sell |
912
-14
| -2% | -$798 | ﹤0.01% | 1567 |
|
|
2017
Q4 | $46K | Buy |
926
+58
| +7% | +$2.88K | ﹤0.01% | 1617 |
|
|
2017
Q3 | $66K | Buy |
+868
| New | +$66K | ﹤0.01% | 1534 |
|